FR2392669B1 - - Google Patents

Info

Publication number
FR2392669B1
FR2392669B1 FR7816125A FR7816125A FR2392669B1 FR 2392669 B1 FR2392669 B1 FR 2392669B1 FR 7816125 A FR7816125 A FR 7816125A FR 7816125 A FR7816125 A FR 7816125A FR 2392669 B1 FR2392669 B1 FR 2392669B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7816125A
Other versions
FR2392669A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richardson Vicks Inc
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Publication of FR2392669A1 publication Critical patent/FR2392669A1/fr
Application granted granted Critical
Publication of FR2392669B1 publication Critical patent/FR2392669B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR7816125A 1977-05-31 1978-05-30 Compositions antihypertensives de clonidine et de phenoxybenzamine Granted FR2392669A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/802,027 US4215130A (en) 1977-05-31 1977-05-31 Antihypertensive compositions of N-(2,6-dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine and N-(2-chloroethyl)-N-(1-methyl-2-phenoxyethyl)-benzenemethanamine

Publications (2)

Publication Number Publication Date
FR2392669A1 FR2392669A1 (fr) 1978-12-29
FR2392669B1 true FR2392669B1 (fr) 1980-04-11

Family

ID=25182653

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7816125A Granted FR2392669A1 (fr) 1977-05-31 1978-05-30 Compositions antihypertensives de clonidine et de phenoxybenzamine

Country Status (14)

Country Link
US (1) US4215130A (fr)
AU (1) AU515368B2 (fr)
BE (1) BE867489A (fr)
CA (1) CA1110170A (fr)
DE (1) DE2823267A1 (fr)
FR (1) FR2392669A1 (fr)
GB (1) GB1573595A (fr)
IE (1) IE46709B1 (fr)
IL (1) IL54505A0 (fr)
NL (1) NL189649C (fr)
NZ (1) NZ186893A (fr)
PH (1) PH13566A (fr)
SE (1) SE434119B (fr)
ZA (1) ZA781920B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4603141A (en) * 1984-11-30 1986-07-29 Giles Thomas D Oral clonidine treatment of congestive heart failure
WO1988005789A1 (fr) * 1987-01-29 1988-08-11 Biotechnology Australia Pty. Ltd. Isolement a partir de fluide folliculaire de proteines a chaine unique avec activite de suppression de la fsh
US5369095A (en) * 1990-02-14 1994-11-29 Alcon Laboratories, Inc. Compositions and method comprising substituted glycosides as mucus membrane permeation enhancers

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2599000A (en) * 1950-09-02 1952-06-03 Smith Kline French Lab Nu, nu-disubstituted-beta-halo-alkylamines
US3236857A (en) * 1961-10-09 1966-02-22 Boehringer Sohn Ingelheim 2-(phenyl-amino)-1, 3-diazacyclopentene-(2) substitution products
US4022893A (en) * 1975-01-24 1977-05-10 Moyer John H Treatment for hypertension

Also Published As

Publication number Publication date
FR2392669A1 (fr) 1978-12-29
DE2823267A1 (de) 1978-12-14
ZA781920B (en) 1979-03-28
US4215130A (en) 1980-07-29
IE780669L (en) 1978-11-30
AU515368B2 (en) 1981-04-02
AU3487778A (en) 1979-10-11
DE2823267C2 (fr) 1987-12-03
NL7804523A (nl) 1978-12-04
IE46709B1 (en) 1983-08-24
NZ186893A (en) 1980-04-28
GB1573595A (en) 1980-08-28
SE434119B (sv) 1984-07-09
SE7806469L (sv) 1979-12-02
NL189649C (nl) 1993-06-16
CA1110170A (fr) 1981-10-06
NL189649B (nl) 1993-01-18
IL54505A0 (en) 1978-07-31
BE867489A (fr) 1978-09-18
PH13566A (en) 1980-06-26

Similar Documents

Publication Publication Date Title
FR2377105B3 (fr)
FR2377554B1 (fr)
FR2378935B1 (fr)
FR2377232B1 (fr)
FR2377360B1 (fr)
FR2379068B1 (fr)
FR2392669B1 (fr)
FR2378623B3 (fr)
FR2376709B1 (fr)
DE2703061C2 (fr)
FR2378103B1 (fr)
FR2378516B1 (fr)
AU71461S (fr)
BG25855A1 (fr)
BG25829A1 (fr)
BG23462A1 (fr)
BE873002A (fr)
BG24331A1 (fr)
BE865722A (fr)
DD131523A5 (fr)
BE872973A (fr)
CH614839A5 (fr)
BG26642A1 (fr)
BG25860A1 (fr)
BG25838A1 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse